about
Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia.Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.Splenic marginal-zone lymphoma: a distinct clinical and pathological entity.CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry.Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup studySmall lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis.Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemia.Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival.Identification of a perinuclear positioning element in human subtelomeres that requires A-type lamins and CTCF.Advances in the role of cytogenetic analysis in the molecular diagnosis of B-cell lymphomas.Cytogenetics in the management of chronic lymphocytic leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).Cytogenetics in the management of lymphomas and lymphoproliferative disorders in adults and children: an update by the Groupe francophone de cytogénétique hématologique (GFCH).Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
P50
Q33310158-2D43664C-E5E7-4715-87FF-F985048DAF10Q33343390-56D42913-AFC6-4631-A704-C480347E68B8Q33346404-B19A95DE-1E7A-44CE-8644-85189677046EQ33800449-20B8C574-6947-4B10-B8EC-D46BBF09C14EQ33856292-1923C27D-E4FB-4ACB-B2E6-A29281421AE4Q34095473-071C2444-4FD1-4DF4-A83C-15BC9387AD58Q34543376-3ABDFC7A-F948-45B3-B97A-AD6B8F41E052Q35824945-965AE6ED-A083-4AE2-BB3D-414365682AFFQ36082131-FED94D06-D533-4E8F-A3E5-E1F6515D48ADQ36624348-9CBD4987-1F65-48D6-8836-C427E3A1816BQ36862542-60005DC2-1878-44F9-A873-9602E43AEB53Q37217181-EB98547D-4F1F-48E4-8203-DCF7DCD01680Q37326478-9CF2F72A-E251-4F56-B414-FDE482D424FDQ38798801-9C666E09-25B3-40BD-93E3-A9BCACC5B153Q38954362-667AAECA-0D4D-43F1-B399-51E14DA2E6FCQ38973035-C8B869EF-740F-437E-A089-BE6F1FDE82DEQ40135160-02C9379B-A6BD-40C2-AFB2-CFE643B297F3Q40414752-F3F7589E-CBFA-4B31-BEEB-11E297CB2AA6
P50
description
onderzoeker
@nl
name
Evelyne Callet-Bauchu
@ast
Evelyne Callet-Bauchu
@en
Evelyne Callet-Bauchu
@es
Evelyne Callet-Bauchu
@sl
type
label
Evelyne Callet-Bauchu
@ast
Evelyne Callet-Bauchu
@en
Evelyne Callet-Bauchu
@es
Evelyne Callet-Bauchu
@sl
prefLabel
Evelyne Callet-Bauchu
@ast
Evelyne Callet-Bauchu
@en
Evelyne Callet-Bauchu
@es
Evelyne Callet-Bauchu
@sl